Company Information

  

Address: 7020 KIT CREEK ROAD
SUITE 270 
City: RESEARCH TRIANGLE PARK 
State: NC 
Zip Code: 27709 
Telephone: 919-313-9650 

Description of Business

Primary SIC Code: 2836
(As filed with the SEC)  

We are an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma and other diseases of the eye. Our strategy is to commercialize Rhopressa┬«, approved by the FDA on December 18, 2017, in North American markets and advance our product candidate, RoclatanTM, to regulatory approval. We are in the process of hiring a commercial team that will include approximately 100 sales representatives to target approximately 12,000 high prescribing eye-care professionals throughout the United States. This sales force will initially be responsible for sales of Rhopressa┬«, and will also be responsible for sales of RoclatanTM, if approved. Our strategy also includes developing our business outside of North America, including obtaining regulatory approval in Europe and Japan on our own for Rhopressa┬« and RoclatanTM.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
03/2018-4.40NAN/E
12/2017-4.11NAN/E
09/2017-3.36NAN/E
06/2017-3.26NAN/E
03/2017-3.31NAN/E
12/2016-3.40NAN/E
09/2016-3.28NAN/E
06/2016-3.17NAN/E

Key Financial Ratios and Statistics

FYE: 12/31

Profitability 2017 Leverage 2017
Net Inc/Comm Equity-0.24Total Liab/Total Assets0.53
Net Inc/Total Assets-0.50Total Liab/Inv Cap0.58
Net Inc/Inv Cap-0.55Total Liab/Comm Equity0.26
Pretax Inc/Net SalesNAInterest Coverage RatioNA
Net Inc/Net SalesNACurr Debt/EquityNA
Cash Flow/Net SalesNALTD/Equity0.91
SG&A/NetSalesNATotal Debt/Equity0.91
Asset Utilization   Liquidity  
Net Receivables TurnoverNAQuick Ratio10.09
Inventory TurnoverNACurrent Ratio10.09
Inventory Day SalesNANet Rec/Curr AssetsNA
Net Sales/Work CapNAInv/Curr AssetsNA
Net Sales/PP&ENA  

Income Statement (Millions)

  3/31/2018 12/31/2017 9/30/2017 6/30/2017
Total Revenues(Net Sales) NA NA NA NA
Cost of Goods Sold NA NA NA NA
Selling & Admin Exps 27.82 22.21 19.77 17.15
Operating Income -40.80 -60.31 -32.18 -27.77
Interest Exp NA NA NA NA
Pretax Income -40.70 -60.41 -32.32 -28.39
Other Income 0.10 -0.10 -0.14 -0.62
Net Income Bef Extraordinary ... NA NA NA NA
Net Income -40.70 -58.51 -32.37 -28.43

Balance Sheet (Millions)

Assets 3/31/2018 12/31/2017 9/30/2017 6/30/2017
Cash & Short Term Investments 333.98 249.66 281.33 307.92
Receivables - Total NA NA NA NA
Inventories - Total 1.06 NA NA NA
Total Current Assets 341.15 254.14 283.40 309.98
Net Property, Plant & Equipment 47.81 31.93 19.25 14.39
Total Assets 391.04 290.28 306.20 326.98
Liabilities        
Accounts Payable 25.14 25.18 18.60 13.81
Debt in Current Liabilities NA NA NA NA
Total Current Liabilities 25.14 25.18 18.60 13.81
Long-Term Debt 123.92 123.85 123.77 123.69
Total Liabilities 154.77 154.68 146.93 141.94
Stockholder's Equity        
Minority Interest NA NA NA NA
Preferred Stock 0.00 0.00 0.00 0.00
Common Stock 0.04 0.04 0.04 0.04
Retained Earnings -504.56 -461.73 -403.22 -370.84
Treasury Stock NA NA NA NA
Total Stockholders' Equity 236.27 135.60 159.27 185.04
Total Liabilities and Stockholders' Equity 391.04 290.28 306.20 326.98

Cash Flow Summary (Millions)

Categories 3/31/2018 12/31/2017 9/30/2017 6/30/2017
Net Cash Provided by Operating Activities -40.84 -26.15 -21.28 -20.93
Net Cash Provided by Investing Activities -41.55 16.79 -27.37 1.39
Net Cash Provided by Financing Activities 134.31 12.85 0.08 122.66

Annual Summary Data (Millions)

Year Sales Net Income EPS
12/20130.00-31.15-6.38
12/20140.00-48.13-2.00
12/20150.00-74.36-2.88
12/20160.00-99.06-3.40
12/20170.00-145.10-4.11
Growth RatesNaN----

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional06/30/1819742,935--




Report Date : 7/16/2018

Powered By Edgar Online © 2018EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.